Medical Genetic Testing: What Your DNA Can (and Can't) Tell Your Doctor

A lot of my patients have already done a genetic test before they ever sit down with me. They spit in a tube, mailed it off, and a few weeks later got a report full of percentages: 2% Scandinavian, elevated odds of curly hair, a note about earwax type. It's fun. It's also, medically speaking, almost useless. And I think that gap — between what people assume their DNA has already told them and what medical genetic testing can actually do — is one of the most common points of confusion in modern preventive care.

Here's the distinction I try to make clear in the office. Ancestry and consumer wellness kits are built for curiosity. Medical genetic testing is built for decisions — the kind that change what medication you're prescribed, what screening you get earlier than your neighbor, or what you eat differently than your spouse even though you're sitting at the same dinner table. Same technology, almost entirely different purpose.

Your genes and your medications don't always get along

Start with a simple, uncomfortable fact: the same dose of the same drug can work beautifully in one person and do almost nothing in another, or cause a side effect severe enough to land them back in my office. Much of that variability comes down to how fast your liver enzymes break a drug down — something written into your DNA long before you were ever prescribed anything.

This is the field called pharmacogenomics, and the evidence behind it has moved well past theory. A randomized clinical trial of more than 660 patients with depression found that those whose antidepressant was chosen using pharmacogenomic testing reached remission nearly 60% more often than those on standard trial-and-error dosing, according to a 2024 randomized clinical trial published in the Journal of Affective Disorders. Not every study has shown gains that dramatic — some larger pragmatic trials have found smaller, though still real, benefits — but the overall pattern is consistent enough that I now think of "start low and see what happens" as an outdated way to prescribe when a simple cheek swab can shorten the guesswork considerably.

This matters most for medications with a narrow margin between "working" and "causing harm" — psychiatric drugs, blood thinners, certain pain medications, some chemotherapy agents. If you've ever cycled through three antidepressants before one finally worked, or watched a family member have an unexpected reaction to a standard dose, that's exactly the problem this kind of testing is designed to shorten.

Risk you can see before it becomes a diagnosis

The second major use of medical genetic testing looks further downstream: not "how will you respond to this drug," but "what are you more likely to develop in the first place." This is where polygenic risk scores come in — tools that combine the small effects of hundreds or thousands of genetic variants into a single risk estimate for conditions like coronary artery disease, type 2 diabetes, or certain cancers.

No single gene variant usually determines your fate here; it's the combined weight of many small nudges, layered on top of your actual lifestyle and lab work. A 2024 review on polygenic risk score implementation in clinical practice found growing evidence that combining these scores with traditional risk factors — blood pressure, cholesterol, family history — improves prediction of both early- and late-onset cardiovascular disease beyond what conventional risk calculators catch alone. That's the heart of proactive, Medicine 3.0 thinking: identifying who's quietly accumulating risk for heart disease at 35, long before a first event forces the conversation at 55.

Even your dinner plate has a genetic dimension

There's a third layer that surprises most patients: your genes also shape how you process food. Two people can eat an identical meal and absorb, metabolize, and store those nutrients along genuinely different pathways — differences in how efficiently you clear caffeine, how you handle saturated fat, or how much folate you actually absorb from a salad versus a supplement. This is the field of nutrigenomics, and a 2024 review in the journal Nutrients lays out a growing body of evidence that genetically informed dietary guidance can meaningfully improve outcomes in conditions like obesity, type 2 diabetes, and cardiovascular disease — precisely because it replaces generic advice with something built around your actual biology.

In my practice, I use genetic and pharmacogenomic testing as a core part of building a plan that truly fits you—not as a gimmick or an occasional add-on. Think of it as another lens: your genes can offer clues about how your body processes certain medications, nutrients, and lifestyle changes, which helps me fine-tune the details of your care. 

That said, your genes are never the whole story. They add helpful context, but they don't override what your history, symptoms, and lab results are telling us—all of it works together. What surprises many people is how few practices actually use this approach; by some estimates, only about one in three integrative and functional medicine practices do. For me, that's exactly why it matters. Taking the time to fold these insights into your plan—carefully and grounded in evidence—is one more way I can offer you care that's genuinely personalized.

This is where an integrative approach earns its keep. A genetic report by itself is just data. The value comes from a physician who can sit with your pharmacogenomic profile, your polygenic risk scores, your nutrigenomic patterns, and your actual bloodwork and history, and weave them into one coherent plan — this medication at this dose, this screening moved up by a decade, this dietary pattern instead of the generic one. That synthesis is the whole point of root-cause, proactive medicine: using every available signal before disease shows up, not after.

What this means for you

If you've already done a consumer ancestry kit, it's not wasted — some of those platforms now offer add-on health reports — but it's rarely built with the clinical rigor or the physician interpretation that turns raw genetic data into a usable medical plan. True medical genetic testing, ordered and interpreted through a clinical lens, can tell us how you'll likely respond to specific medications, where your inherited risk is quietly building before symptoms appear, and how your body actually handles the food you eat. None of that replaces good judgment, a thorough history, or your own lived experience of your body. It sharpens all three.

If you're curious what your own genetic profile might reveal — about medications, long-term risk, or how your body processes food — you can schedule a free consultation with us at Dignity Integrative. We'll walk through what testing actually makes sense for you, and what it doesn't.